The APCs can recognize and capture extracellular proteins from tumor cells and present them as antigen-derived peptides to CD4+ and CD8+ T-lymphocytes by the major histocompatibility complex molecules of class I and II (MHC-I and MHC-II) expressed by these cells; this is a critical step for an effective adaptive immune response [4]. This evidence concerns the gene CD8A and neoplasm.